{"name":"TFF Pharmaceuticals, Inc.","slug":"tff-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":733871,"revenueGrowth":48,"grossMargin":0,"rdSpend":12061422,"netIncome":-21243231,"cash":5478113,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2023"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Voriconazole Inhalation Powder","genericName":"Voriconazole Inhalation Powder","slug":"voriconazole-inhalation-powder","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Voriconazole Inhalation Powder","genericName":"Voriconazole Inhalation Powder","slug":"voriconazole-inhalation-powder","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-12","type":"pipeline","source":"GlobeNewswire","summary":"Pharmaceutical and Biotechnology Royalty Rates Agreements - GlobeNewswire","headline":"Pharmaceutical and Biotechnology Royalty Rates Agreements","sentiment":"neutral"},{"date":"2025-03-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNMTNlRDBQYVVXOTVucXJKZkdMd1h3M0JsanJpU3AxUmU0TjZYRWluenp6eXJKMEhUSXVHbTZUaFR4S3dta0VQVFZ4VXFCY1Z4c3FIc2NwU2lqMF9YNC1KZjBkUXREOGxhenM3MnFqSnBaX3I3d3JkYmktaFZ6OVRKLVp0VmxzaW1YX3RJMVhVYmo0bmZzaHZCVUtHMFR0cFUxRDhlX0pBZzlsLWw3ZW9KNHRvdzQ0VlpzcHpGTQ?oc=5","date":"2025-02-06","type":"pipeline","source":"Stock Titan","summary":"TFF Pharmaceuticals to Exit Nasdaq: Complete Liquidation Plan Leaves Shareholders in Limbo - Stock Titan","headline":"TFF Pharmaceuticals to Exit Nasdaq: Complete Liquidation Plan Leaves Shareholders in Limbo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPWFpXcXVNRG96TG5yVmpKUldxc0RucHBDYjQ2RGhaeFI2NjZyUFZ2TXNnLUJRX0ZlUnBXSnB4MFd6cmJpYXBmcWdYNHNsQ0hPcng4N0tCc2tNV2pzR2R3RTJOT0VNRzkzLVc0N0RaaDR3WHZvZHJJSml5UEY5RUpRRDlBU1FUV0RzTmZiQ0lmZTk1TThDOGFZ?oc=5","date":"2025-02-06","type":"pipeline","source":"Yahoo Finance","summary":"TFF Pharmaceuticals Announces Delisting from Nasdaq and Potential SEC Deregistration - Yahoo Finance","headline":"TFF Pharmaceuticals Announces Delisting from Nasdaq and Potential SEC Deregistration","sentiment":"neutral"},{"date":"2025-02-03","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2024-12-10","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2024-11-20","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: QUARTERLY REPORT","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPMWlvUmtGbExQQU9wVmVhS0tSeEFxYnVJWTgxVDQ4aWpQUl9DenRwcGhfbUxPR2VmZ3JYVFpfcEE5V0xfZnVuUllqdThoRk81eW5wQmxSa3pJN09hMHRzQ3lkYUdRRVM0VnV3V1hUVUdmVHFzaWNQRzl0bnRzcC01eFBreDJ1RW9vR2Y5SFFPMzBJVk1UelBhMFM2TE5PcVo2U3ptTw?oc=5","date":"2024-11-14","type":"pipeline","source":"Stock Titan","summary":"TFF Pharmaceuticals Announces Complete Shutdown, Appoints Wind-Down Specialist as CEO - Stock Titan","headline":"TFF Pharmaceuticals Announces Complete Shutdown, Appoints Wind-Down Specialist as CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOT1lTNk5TcGc2S3hfREVRN0ZTbEFvSEU4TERxTEcza1p5SXFXWEZ6UW50RTZtMkV5X01IMzd2MnVsZmROYjQ3T1Q2dm9kcmJiWVNCcFlUX3JFTHNJV1pjY1VITnk0YVFkMENhd2V0Q3Q2Mk9xRGFINEdpYnpoOTFXS3FpSlhOLVpDZHI1RVZ6Yjhfbk9UUVNnRjUwbHJ3WmhCYXc?oc=5","date":"2024-07-02","type":"patent","source":"Pharmaceutical Technology","summary":"FTC investigates Teva over contested product patents - Pharmaceutical Technology","headline":"FTC investigates Teva over contested product patents","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNbnNUVjllSi1MNERmcnY5MUI1dFhNekpYejQ3SXJOM0thMVJTUjBCVmNtY3hGOXR6bExNT25sUDZrd3NkcVFZVVZVWUhaMGlmMmhuNmlxSk03TUhwZlktcjJJXy1UMHQxaGNuQmdkSG14NGNTUlZ6NzZqQVgwSGNfVTF0YmFKbG9DSE9FWg?oc=5","date":"2023-07-31","type":"pipeline","source":"Yahoo Finance","summary":"TFF Pharmaceuticals Inc. and Uniphar Durbin Ireland Ltd. Announce the Opening of an Expanded Access Program for Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Pulmonary Aspergillosis a","headline":"TFF Pharmaceuticals Inc. and Uniphar Durbin Ireland Ltd. Announce the Opening of an Expanded Access Program for Voricona","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOb3VidVNCWGhLU3ZZTlVabG1Mbk9ZRmVCVk9IRVRsek93WDBYRzZlanRtNk1qWlV0OERMR1djMWIzelJTUG5mYTUyRndmY29OcE1GMzFLNVJCMmo1OHNZQTBuR2dFWXI0emRXd3B5MzVSaGVjSlVMdk11NGtrOHJyYm1DNFh6YVhNelh1di1BWTJyYWd0SDlXQ1R3?oc=5","date":"2022-12-05","type":"pipeline","source":"citybiz","summary":"TFF Pharmaceuticals Appoints Harlan Weisman Interim CEO - citybiz","headline":"TFF Pharmaceuticals Appoints Harlan Weisman Interim CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxOSklKbGw1eDhxWHlaMU1IUzBYd3c2cWwtaGJldVllZnUzQ3BRdE4yRXB6d1h1dmZtWkJaSVlyQ2YzZG9vcjJTQ0hyWGZuMmNyQV82M3NIT05IdUhzUmt4SW1VUFc5V3ZlREd1aWNDLU5jSnRaM0pabTdHUHZ3ZUI5WUVrZEczT0JHOG8yRHRwVW5vdnhKZm12TUQ3Y29rOFJWR1V4X3REYWw5RVh6a25PaVBrV1BzR0FYZlRBdFhFOHFQRnd0eEluNGVhUzlubVRFUHEyWnVn?oc=5","date":"2022-11-07","type":"deal","source":"Aptar","summary":"Aptar Pharma Announces Collaboration with TFF Pharmaceuticals - Aptar","headline":"Aptar Pharma Announces Collaboration with TFF Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxPT3VPRXMydVFHbWQtWUxnSzBuS0ZZSHpjYUhraHYzbW40b0RUUWtobUR5blg0NktwR1R3d2ZXWnlpcFdTb2xsT09wN0xCWkIyQVZWaXktdlpnYnZQaHlONXlFdW9XRWVwSW9Zd0NaUmpDUWlyeVVNNFdmSmpabU9Ba3FRVW13bUlXZ1Bfa0MzUXZqMGI3bUh2YWVvRTAwTzZNcjhscnN3RFJXXzkxN1Q0WGNFRjA0UEF4SjZ6cS1ZTlRHWFVxSENmME1nUmhNY0N2?oc=5","date":"2021-09-23","type":"trial","source":"drugdiscoverytrends.com","summary":"TFF Pharmaceuticals sees promise in Phase 1 trial of inhaled tacrolimus powder for lung transplant - drugdiscoverytrends.com","headline":"TFF Pharmaceuticals sees promise in Phase 1 trial of inhaled tacrolimus powder for lung transplant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOM0NLYkdYU1RTcWllSGRGSmRLX3lZT2hsZXNVTDdGbER6SVdqang2MmExLTJMeUVxZnFlV25vRlROM1dXVWhtT0tuU0k3NHFHYnVjWHhqa3hXOUlMVmFQamx0UVVpZUx2MWZ6cjNVclRJWE1iQlE5Z01MbUFFazQ2Nl9OeUZhaG5acnV3?oc=5","date":"2020-10-06","type":"pipeline","source":"Contract Pharma","summary":"Irisys Signs Contract with TFF Pharma - Contract Pharma","headline":"Irisys Signs Contract with TFF Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOVFYwcS1vREFuS095RVRueTdLM3l6NFJRN09oSkNwQmdZRHJSdUN5Qk1fSkhrandaWVNKMkpOeVVJOFd1cUlHamhISkUxQU54OUNMZ2Z5cjRhcmhKaXJiWGhWTHJvM2d1UHQ5eE1NTWRLSmRDaXhtSDRPOFJyQkFGRk13MGJZanZyZ3BxSEhJZ0MwN2RncUtlNUR1WVIzUUFqTmlqUkw5QjhVa0xDZ2s4aWpQOUNSTVJ3czFzTTk0SkRnZXVOUThMVU1XRjJ2UklUb0F2VU5yY1R3Y0g3bnhDQ0c1WQ?oc=5","date":"2020-01-28","type":"pipeline","source":"Business Wire","summary":"Ascend Capital Founder Malcolm Fairbairn Appointed to TFF Pharmaceuticals Board of Directors - Business Wire","headline":"Ascend Capital Founder Malcolm Fairbairn Appointed to TFF Pharmaceuticals Board of Directors","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":3,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":733871,"revenuePeriod":"2023-12-31","revenueHistory":[{"value":733871,"period":"2023-12-31"},{"value":495805,"period":"2022-12-31"},{"value":88161,"period":"2021-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":12061422,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-21243231,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":5478113,"cashHistory":[],"totalAssets":12027316,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}